Biomedical (BASIC)

Ended Indefinite Delivery Contract Awarded Last action

Contract number
HHSN268201100007I
Awardee
Awarding agency
Task orders
3 $8,927,257 obligated

Award facts

Opportunity
Combined order value
$8,927,257 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 94% used
$9,466,198.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 5 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

About this IDV

This indefinite delivery contract (IDC) was awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the Department of Health and Human Services (HHS), to Vitalant Research Institute (VRI), the research arm of the nonprofit Vitalant organization. The contract, valued at up to $9.47 million, supports the NHLBI's Recipient Epidemiology and Donor Evaluation Study III (REDS-III) International program, which focuses on blood safety and availability issues globally.

Under this IDC, VRI has been awarded multiple delivery orders to provide epidemiological and donor evaluation services for the REDS-III study in Brazil. Key tasks include establishing a sickle cell disease patient cohort, evaluating transfusion strategies and risks, and conducting clinical protocol implementation and data analysis. VRI has subcontracted portions of the work to the University of Sao Paulo, UCSF Benioff Children's Hospital Oakland, and the Fundacao Faculdade de Medicina. The contract has a period of performance through March 2020 and does not utilize any set-asides, with work primarily based in San Francisco, California.

Task orders

Task order Ordering agency Obligated Awarded
Dbdr reds-III international sites phase 3 HHSN26800003 National Heart Lung and Blood Institute (NIH) $716,543
Reds-III HHSN26800002 National Heart Lung and Blood Institute (NIH) $5,694,454
Biomedical (BASIC) HHSN26800001 National Heart Lung and Blood Institute (NIH) $2,516,260

Transactions

Action Obligated Date
Close Out P00010 $0
Change Order 9 · Dbdr reds-III international site (BRAZIL) $0
Other Administrative Action 8 $0
Change Order 7 $0
Other Administrative Action 6 $0
Other Administrative Action 5 $0
Other Administrative Action 4 · Recipient epidemiology and donor evaluation study III (REDS-III) - international site $0
Supplemental Agreement for work within scope 3 $0
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $0
Show all 11

Quick answers

Who was awarded contract HHSN268201100007I?

HHSN268201100007I was awarded to Vitalant by National Heart Lung and Blood Institute (National Institutes of Health) on March 21, 2011.

How much is contract HHSN268201100007I worth?

Orders under HHSN268201100007I have obligated $8,927,257. HHSN268201100007I's own ceiling is $9,466,198.

How many orders have been placed under contract HHSN268201100007I?

3 orders have been placed under HHSN268201100007I, the latest on September 27, 2017.

Who can order from contract HHSN268201100007I?

HHSN268201100007I is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract HHSN268201100007I competed?

The extent of competition for HHSN268201100007I was full and open competition. The government received 5 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV